RhythmAnalytics vs Cardiologs Holter Platform

Direct competitors — feature-level head-to-head below. Comparability 88/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by Philips France Commercial

AI Verdict

Both RhythmAnalytics and Cardiologs Holter Platform are FDA-cleared, AI-powered cloud solutions for cardiac arrhythmia detection and ECG analysis, making them direct competitors. RhythmAnalytics focuses on automated interpretation from single-lead ECG data, including compatibility with wearable sensors, offering broader input versatility. In contrast, the Cardiologs Holter Platform is specifically designed to streamline and accelerate dedicated Holter ECG analysis workflows.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from diverse single-lead ECG data sources, including wearable sensors and event recorders, for real-time or near real-time clinical decision support. This tool is ideal for integrators looking for a cloud-based API to enhance existing monitoring platforms with advanced arrhythmia detection capabilities across various ECG device types.

View RhythmAnalytics →

Choose Cardiologs Holter Platform if…

Choose the Cardiologs Holter Platform if your focus is on significantly streamlining and accelerating the analysis of traditional Holter ECG recordings. This solution is best suited for practices seeking a vendor-neutral, cloud-based AI platform to reduce Holter analysis time by nearly half, while ensuring accurate detection of a wide range of arrhythmias and seamless integration with EMR systems.

View Cardiologs Holter Platform →

When choosing between RhythmAnalytics by Biofourmis and the Cardiologs Holter Platform by Philips, physicians should consider their primary use case and existing infrastructure. RhythmAnalytics excels in providing automated interpretation of cardiac arrhythmias from single-lead ECG data, making it suitable for a broad range of compatible FDA-cleared ECG devices, including Holter, event recorders, and wearable sensors. Its strength lies in its cloud-based API deployment, which facilitates integration into diverse healthcare IT environments and supports clinical decision-making across specialties like Cardiology, Emergency Medicine, and Internal Medicine.

In contrast, the Cardiologs Holter Platform is specifically designed for fast and accurate Holter ECG analysis, detecting over 20 types of arrhythmias and significantly reducing analysis time. Its vendor-neutral compatibility with multiple Holter devices and integration capabilities with EMR systems, particularly Philips IntelliBridge Enterprise, make it ideal for practices focused on streamlining Holter diagnostics. The key practical difference lies in their scope: RhythmAnalytics offers broader compatibility with various single-lead ECG sources, while Cardiologs is optimized for the specific workflow of Holter analysis.

Therefore, a physician seeking a versatile AI tool for interpreting cardiac arrhythmias from a variety of single-lead ECG devices, including wearables, might lean towards RhythmAnalytics. Conversely, a cardiology practice primarily focused on optimizing and accelerating their Holter ECG analysis workflow, especially one already utilizing Philips’ ecosystem, would likely find the Cardiologs Holter Platform to be a more tailored and efficient solution.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics Cardiologs Holter Platform
Pricing Contact vendor Contact sales
Deployment Cloud-based API Cloud-based (SaaS)
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiologs Holter Platform

Tool B, the Cardiologs Holter Platform, is described as a cloud-based platform that generates easy-to-read, automatically enriched reports and significantly reduces analysis time, indicating a direct, user-friendly interface for clinicians. Tool A, RhythmAnalytics, is primarily a cloud-based API for integration, suggesting it's more of a backend service for developers rather than a direct end-user application.

Clinical Value

Cardiologs Holter Platform

Both tools are FDA-cleared and offer significant clinical value. However, Tool B explicitly states it detects 'over 20 types of arrhythmias' compared to Tool A's 'over 15 types,' and quantifies a substantial '42% reduction in analysis duration', directly enhancing clinical efficiency and diagnostic throughput.

Pricing & Value

Cardiologs Holter Platform

Tool B offers more transparency in its pricing model by specifying a 'Pay per ECG regardless the number of users' structure and explicitly confirms the availability of a Business Associate Agreement (BAA). Tool A's pricing and BAA status are unspecified, making it harder to assess its overall value proposition.

Enterprise Readiness

Cardiologs Holter Platform

While both are HIPAA compliant and FDA cleared, Tool B demonstrates superior enterprise readiness by explicitly confirming BAA availability, offering specific EMR integration (Philips IntelliBridge Enterprise), and detailing secure data hosting on ISO/IEC 27001 certified AWS servers. Tool A lacks these explicit details, which are crucial for enterprise adoption.

Innovation

Cardiologs Holter Platform

Both tools leverage AI and deep learning for arrhythmia detection. However, Tool B explicitly highlights itself as the 'first FDA-cleared ECG analysis solution powered by deep learning technology' and provides a quantifiable benefit of a '42% reduction in analysis duration', showcasing a clear and impactful innovative advantage.

Support & Docs

Cardiologs Holter Platform

Tool B clearly outlines avenues for technical support, directing users to contact support via its platform's 'Help' menu and providing access to documentation, brochures, and white papers. In contrast, specific support and documentation for Tool A's RhythmAnalytics API are not readily detailed in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics Cardiologs Holter Platform
Name RhythmAnalytics Cardiologs Holter Platform
Company Biofourmis Singapore Pte. Philips France Commercial
Tagline AI-powered automated interpretation of cardiac arrhythmias for enhanced clinical decision support. Reinventing cardiology diagnostics with medical-grade AI and cloud technology.
Arrhythmia Types Detected Over 15 types (including AFib, ventricular arrhythmias, ectopic beats) Over 20 types
Key Technology AI-based automated interpretation AI-powered deep learning technology for ECG analysis
Integration Capabilities Cloud-based API for integration; Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors) Vendor-neutral compatibility with multiple Holter devices; Integration with Electronic Medical Record (EMR) systems (Philips IntelliBridge Enterprise)

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and Cardiologs Holter Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics by Biofourmis is designed to detect over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats. The Cardiologs Holter Platform by Philips is capable of detecting over 20 types of arrhythmias.
RhythmAnalytics offers compatibility with FDA-cleared ECG devices such as Holter, event recorders, and wearable sensors. The Cardiologs Holter Platform provides vendor-neutral compatibility with multiple Holter devices.
RhythmAnalytics offers a cloud-based API for integration with other systems. The Cardiologs Holter Platform integrates with Electronic Medical Record (EMR) systems, specifically mentioning Philips IntelliBridge Enterprise.
RhythmAnalytics provides AI-based automated interpretation of cardiac arrhythmias for enhanced clinical decision support and performs beat-by-beat morphology computation. The Cardiologs Holter Platform is noted for reducing Holter analysis time by approximately 42% and generating easy-to-read, automatically enriched reports.
Both RhythmAnalytics and the Cardiologs Holter Platform are FDA-cleared and HIPAA compliant. The Cardiologs Holter Platform further specifies secure data hosting on ISO/IEC 27001 certified AWS servers and confirms having a Business Associate Agreement (BAA), whereas RhythmAnalytics' BAA status is unspecified.
AI Tool Finder
AI-powered search. Results may not be comprehensive.